Barclays’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $466K | Buy |
116,142
+69,475
| +149% | +$279K | ﹤0.01% | 3071 |
|
|
2025
Q1 | $163K | Sell |
46,667
-8,494
| -15% | -$29.7K | ﹤0.01% | 3442 |
|
|
2024
Q4 | $363K | Buy |
55,161
+4,951
| +10% | +$32.6K | ﹤0.01% | 3234 |
|
|
2024
Q3 | $454K | Buy |
50,210
+31,057
| +162% | +$281K | ﹤0.01% | 3050 |
|
|
2024
Q2 | $308K | Sell |
19,153
-3,776
| -16% | -$60.7K | ﹤0.01% | 2807 |
|
|
2024
Q1 | $359K | Buy |
22,929
+7,412
| +48% | +$116K | ﹤0.01% | 3020 |
|
|
2023
Q4 | $208K | Buy |
+15,517
| New | +$208K | ﹤0.01% | 3491 |
|